106 related articles for article (PubMed ID: 18488097)
1. Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications.
Cardoso BA; Gírio A; Henriques C; Martins LR; Santos C; Silva A; Barata JT
Braz J Med Biol Res; 2008 May; 41(5):344-50. PubMed ID: 18488097
[TBL] [Abstract][Full Text] [Related]
2. Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation.
Hasan M; Neumann B; Haupeltshofer S; Stahlke S; Fantini MC; Angstwurm K; Bogdahn U; Kleiter I
Immunol Cell Biol; 2015 Aug; 93(7):662-72. PubMed ID: 25823994
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways.
Zhao WL
Leukemia; 2010 Jan; 24(1):13-21. PubMed ID: 19865108
[TBL] [Abstract][Full Text] [Related]
4. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways in cancer and embryonic stem cells.
Dreesen O; Brivanlou AH
Stem Cell Rev; 2007 Jan; 3(1):7-17. PubMed ID: 17873377
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling and its integration with other signaling mechanisms.
Sahlgren C; Lendahl U
Regen Med; 2006 Mar; 1(2):195-205. PubMed ID: 17465803
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
Barata JT; Cardoso AA; Boussiotis VA
Leuk Lymphoma; 2005 Apr; 46(4):483-95. PubMed ID: 16019476
[TBL] [Abstract][Full Text] [Related]
8. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
[TBL] [Abstract][Full Text] [Related]
9. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
10. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.
Luo JM; Cen LP; Zhang XM; Chiang SW; Huang Y; Lin D; Fan YM; van Rooijen N; Lam DS; Pang CP; Cui Q
Eur J Neurosci; 2007 Aug; 26(4):828-42. PubMed ID: 17714182
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.
Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ
Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.
Rodríguez-Barbero A; Dorado F; Velasco S; Pandiella A; Banas B; López-Novoa JM
Kidney Int; 2006 Sep; 70(5):901-9. PubMed ID: 16820791
[TBL] [Abstract][Full Text] [Related]
13. The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses.
Yu Q; Kovacs C; Yue FY; Ostrowski MA
J Immunol; 2004 May; 172(10):6047-56. PubMed ID: 15128788
[TBL] [Abstract][Full Text] [Related]
14. Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells.
Xie J; Qian J; Yang J; Wang S; Freeman ME; Yi Q
Exp Hematol; 2005 May; 33(5):564-72. PubMed ID: 15850834
[TBL] [Abstract][Full Text] [Related]
15. Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway.
Dedoni S; Olianas MC; Onali P
J Neurochem; 2010 Dec; 115(6):1421-33. PubMed ID: 21044071
[TBL] [Abstract][Full Text] [Related]
16. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
[TBL] [Abstract][Full Text] [Related]
17. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
Guo D; Teng Q; Ji C
Leuk Lymphoma; 2011 Jul; 52(7):1200-10. PubMed ID: 21463127
[TBL] [Abstract][Full Text] [Related]
18. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
Canté-Barrett K; Spijkers-Hagelstein JA; Buijs-Gladdines JG; Uitdehaag JC; Smits WK; van der Zwet J; Buijsman RC; Zaman GJ; Pieters R; Meijerink JP
Leukemia; 2016 Sep; 30(9):1832-43. PubMed ID: 27174491
[TBL] [Abstract][Full Text] [Related]
19. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
20. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
